Cindy Lepkin

The number of adults taking GLP-1 drugs, which include Ozempic, Wegovi, Zephound, and Manjaro, is going up.

It went from 6 percent a year and a half ago to 12 percent now.

People are taking the drugs for chronic conditions like type 2 diabetes and heart disease, as well as for weight loss.

Here's Ashley Kurtzinger, a pollster at KFF.

Although most people taking these drugs say they have some insurance coverage for them, more than half say the drugs are difficult to afford.

KFF conducted the poll between October 27th and November 2nd.

Sydney Lepkin, NPR News.